M1469 – Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period

Long description

Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period

Short description

Hx of hep b, or pos bld test

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2026

Last change

January 1, 2026 – No change

Nearby M codes

• M1461 – Patient diagnosis for chronic hepatitis c
• M1462 – Patients with clinical indications for imaging of the head
• M1463 – Documentation of at least two attempts to follow up with patient within 180 days of treatment
• M1464 – No documentation of at least two attempts to follow up with patient within 180 days of treatment
• M1465 – Patient follow up more than 180 days after treatment
• M1466 – Patient had a lumbar fusion on the same date as the discectomy/laminectomy procedure
• M1467 – Patients with an existing diagnosis of lynch syndrome
• M1468 – Patient received recommended doses of hepatitis b vaccination based on age
• M1470 – Documentation of medical reason(s) for not administering hepatitis b vaccine (e.g., prior anaphylaxis due to the hepatitis b vaccine)
• M1471 – Documentation that patient is a medicare fee-for-service beneficiary and without additional supplementary insurance coverage for whom hep b vaccination is not reimbursable under current medicare part b coverage rules
• M1472 – Patient did not receive recommended doses of hepatitis b vaccination based on age
• M1473 – Patient situations, at any point during the denominator identification period, where the patient's functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools, such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders
• M1474 – Patients with diagnosis of dementia
• M1475 – Patients with diagnosis of huntington's disease
• M1476 – Patients with diagnosis of cognitive impairment or alzheimer's disease
• M1477 – Diagnosis of delirium